ABSTRACT
Depression after stroke is common. Although different opinions exist about the definition,
diagnosis, and measurement of outcomes related to depression after stroke, there is
little debate about the prevalence of depression symptoms and their impact on stroke
survivors and their families. Depression after stroke has long been recognized as
a common condition with many negative effects in the poststroke period, but more recently
depression has also been identified as an independent stroke risk factor. Given that
there are at least 500,000 new ischemic strokes yearly in the United States, a conservative
estimate is that 150,000 U.S. stroke survivors develop poststroke depression each
year. Because effective treatments exist but are likely underutilized for depression,
this is an important example of an evidence-practice gap to which increased efforts
to improve care should be made. Such efforts would likely improve not only patient
symptoms but may also decrease stroke risk, influence stroke functional recovery,
decrease mortality, and reduce poststroke health care utilization. This article provides
an overview of depression diagnosis in stroke, reviews the epidemiology of poststroke
depression and its associated morbidity and mortality, and reviews existing evidence
on the treatment and prevention of poststroke depression.
KEYWORDS
Stroke - depression - recovery - risk factors
REFERENCES
1
Gordon W A, Hibbard M R.
Poststroke depression: an examination of the literature.
Arch Phys Med Rehabil.
1997;
78
658-663
2
Gordon W A, Hibbard M R, Egelko S et al..
Issues in the diagnosis of post-stroke depression.
Rehabil Psychol.
1991;
36
71-87
3
Starkstein S E, Robinson R G.
Affective disorders and cerebral vascular disease.
Br J Psychiatry.
1989;
154
170-182
4
Black K J.
Diagnosing depression after stroke.
South Med J.
1995;
88
699-708
5
Paradiso S, Ohkubo T, Robinson R G.
Vegetative and psychological symptoms associated with depressed mood over the first
two years after stroke.
Int J Psychiatry Med.
1997;
27
137-157
6
Mosnik D, Williams L S, Kroenke K, Callahan C.
Symptoms of post-stroke depression: a distinct syndrome compared to geriatric depression
[abstract].
Neurology.
2000;
54(suppl 3)
A378-A379
7
Williams L S, Brizendine E J, Plue L et al..
Performance of the PHQ-9 as a screening tool for post-stroke depression.
Stroke.
2005;
36
635-638
8
Morris P L, Robinson R G, Raphael B.
Emotional lability after stroke.
Aust N Z J Psychiatry.
1993;
27
601-605
9
Calvert T, Knapp P, House A.
Psychological associations with emotionalism after stroke.
J Neurol Neurosurg Psychiatry.
1998;
65
928-929
10
Bogousslavsky J.
William Feinberg lecture 2002: emotions, mood, and behavior after stroke.
Stroke.
2003;
34
1046-1050
11
Johnson G, Burvill P W, Anderson C S, Jamrozik K, Stewart-Wynne E G, Chakera T M.
Screening instruments for depression and anxiety following stroke: experience in the
Perth Community Stroke Study.
Acta Psychiatr Scand.
1995;
91
252-257
12
Gainotti G, Azzoni A, Razzano C, Lanzillotta M, Marra C, Gasparini F.
The Post-Stroke Depression Rating Scale: a test specifically devised to investigate
affective disorders of stroke patients.
J Clin Exp Neuropsychol.
1997;
19
340-356
13
O'Rourke S, MacHale S, Signorini D, Dennis M.
Detecting psychiatric morbidity after stroke: comparison of the GHQ and the HAD Scale.
Stroke.
1998;
29
980-985
14
Aben I, Verhey F, Lousberg R, Lodder J, Honig A.
Validity of the Beck depression inventory, hospital anxiety and depression scale,
SCL-90, and Hamilton depression rating scale as screening instruments for depression
in stroke patients.
Psychosomatics.
2002;
43
386-393
15
Lincoln N B, Nicholl C R, Flannaghan T, Leonard M, Van der Gucht E.
The validity of questionnaire measures for assessing depression after stroke.
Clin Rehabil.
2003;
17
840-846
16
Spitzer R L, Kroenke K, Williams J BW.
Patient Health Questionnaire Study Group. Validity and utility of a self-report version
of PRIME-MD: the PHQ Primary Care Study.
JAMA.
1999;
282
1737-1744
17
Kroenke K, Spitzer R L, Williams J BW.
The PHQ-9: validity of a brief depression severity measure.
J Gen Intern Med.
2001;
16
606-613
18
Davies S JC, Jackson P R, Potokar J, Nutt D J.
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
BMJ.
2004;
328
939-943
19
Whyte E M, Mulsant B H, Vanderbilt J, Dodge H H, Ganguli M.
Depression after stroke: a prospective epidemiological study.
J Am Geriatr Soc.
2004;
52
774-778
20
Ostir G V, Markides K S, Peek M K, Goodwin J S.
The association between emotional well-being and the incidence of stroke in older
adults.
Psychosom Med.
2001;
63
210-215
21
Ostir G V, Goodwin J S, Markides K S, Ottenbacher K J, Balfour J, Guralnik J M.
Differential effects of premorbid physical and emotional health on recovery from acute
events.
J Am Geriatr Soc.
2002;
50
713-718
22
Jonas B S, Mussolino M E.
Symptoms of depression as a prospective risk factor for stroke.
Psychosom Med.
2000;
62
463-471
23
Ohira T, Iso H, Satoh S et al..
Prospective study of depressive symptoms and risk of stroke among Japanese.
Stroke.
2001;
32
903-908
24
Nilsson F M, Kessing L V.
Increased risk of developing stroke for patients with major affective disorder: a
registry study.
Eur Arch Psychiatry Clin Neurosci.
2004;
254
387-391
25
Lyness J M.
The cerebrovascular model of depression in late life.
CNS Spectr.
2002;
7
712-715
26
Mast B T, MacNeill S E, Lichtenberg P A.
Post-stroke and clinically-defined vascular depression in geriatric rehabilitation
patients.
Am J Geriatr Psychiatry.
2004;
12
84-92
27
Thomas A J, Kalaria R N, O'Brien J T.
Depression and vascular disease: what is the relationship?.
J Affect Disord.
2004;
79
81-95
28
Gump B B, Matthews K A, Eberly L E, Chang Y F.
Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention
Trial.
Stroke.
2005;
36
98-102
29
Everson S A, Roberts R E, Goldberg D E, Kaplan G A.
Depressive symptoms and increased risk of stroke mortality over a 29-year period.
Arch Intern Med.
1998;
158
1133-1138
30
Cassidy E M, Walsh M T, O'Connor R et al..
Platelet surface glycoprotein expression in post-stroke depression: a preliminary
study.
Psychiatry Res.
2003;
118
175-181
31
Rasmussen A, Christensen J, Clemmensen P M et al..
Platelet serotonin transporter in stroke patients.
Acta Neurol Scand.
2003;
107
150-153
32
Ramasubbu R.
Serotonin transporter gene functional polymorphism: a plausible candidate gene for
increased vascular risk in depression.
Med Hypotheses.
2003;
61
36-44
33
Serebruany V L, Glassman A H, Malinin A I et al..
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin
reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant
Heart Attach Randomized Trial (SADHART) Platelet Substudy.
Circulation.
2003;
108
939-944
34
Berkman L F, Blumenthal J, Burg M et al..
Effects of treating depression and low perceived social support on clinical events
after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients
(ENRICHD) Randomized Trial.
JAMA.
2003;
289
3106-3116
35
Black S A, Markides K S, Ray L A.
Depression predicts increased incidence of adverse health outcomes in older Mexican
Americans with type 2 diabetes.
Diabetes Care.
2003;
26
2822-2828
36
Kiecolt-Glaser J K, McGuire L, Robles T F, Glaser R.
Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology.
Annu Rev Psychol.
2002;
53
83-107
37
Penninx B W, van Tilburg T, Kriegsman D M, Deeg D J, Boeke A J, van Eijk J T.
Effects of social support and personal coping resources on mortality in older age:
the Longitudinal Aging Study Amsterdam.
Am J Epidemiol.
1997;
146
510-519
38
Licinio J, Wong M L.
The role of inflammatory mediators in the biology of major depression: central nervous
system cytokines modulate the biological substrate of depressive symptoms, regulate
stress-responsive systems, and contribute to neurotoxicity and neuroprotection.
Mol Psychiatry.
1999;
4
317-327
39
Morey M C, Pieper C F, Crowley G M, Sullivan R J, Publisi C M.
Exercise adherence and 10-year mortality in chronically ill older adults.
J Am Geriatr Soc.
2002;
50
1929-1933
40
Jonas B S, Lando J F.
Negative affect as a prospective risk factor for hypertension.
Psychosom Med.
2000;
62
188-196
41
Davidson K, Jonas B S, Dixon K E, Markovitz J H.
Do depression symptoms predict early hypertension incidence in young adults in the
CARDIA study? Coronary Artery Risk Development in Young Adults.
Arch Intern Med.
2000;
160
1495-1500
42
Andersen G, Vestergaard K, Riis J O, Lauritzen L.
Incidence of poststroke depression during the first year in a large unselected stroke
population determined using a valid standardized rating scale.
Acta Psychiatr Scand.
1994;
90
190-195
43
Astrom M, Adolfsson R, Asplund K.
Major depression in stroke patients: a 3-year longitudinal study.
Stroke.
1993;
24
976-982
44
Burvill P W, Johnson G A, Jamrozik K D, Anderson C S, Stewart-Wynne E G, Chakera T M.
Prevalence of depression after stroke: the Perth Community Stroke Study.
Br J Psychiatry.
1995;
166
320-327
45
Fuh J L, Liu H C, Wang S J, Liu C Y, Wang P N.
Poststroke depression among the Chinese elderly in a rural community.
Stroke.
1997;
28
1126-1129
46
Ghika-Schmid F, Bogousslavsky J.
Affective disorders following stroke.
Eur Neurol.
1997;
38
75-81
47
Herrmann N, Black S E, Lawrence J, Szekely C, Szalai J P.
The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional
outcomes.
Stroke.
1998;
29
618-624
48
House A, Dennis M, Warlow C, Hawton K, Molyneux A.
Mood disorders after stroke and their relation to lesion location: a CT scan study.
Brain.
1990;
113
1113-1129
49
Kotila M, Numminen H, Waltimo O, Kaste M.
Depression after stroke: results of the FINNSTROKE study.
Stroke.
1998;
29
368-372
50
Robinson R G, Price T R.
Post-stroke depressive disorders: a follow-up study of 103 patients.
Stroke.
1982;
13
635-641
51
Robinson R G, Starr L B, Price T R.
A two year longitudinal study of mood disorders following stroke: prevalence and duration
at six months follow-up.
Br J Psychiatry.
1984;
144
256-262
52
Pohjasvaara T, Leppavuori A, Siira I, Vataja R, Kaste M, Erkinjuntti T.
Frequency and clinical determinants of poststroke depression.
Stroke.
1998;
29
2311-2317
53
Robinson R G, Starr L B, Kubos K L, Price T R.
A 2-year longitudinal study of post-stroke mood disorders: findings during the initial
evaluation.
Stroke.
1983;
14
736-741
54
Toso V, Gandolfo C, Paolucci S, Provinciali L, Torta R, Grassivaro N. DESTRO Study
Group .
Post-stroke depression: research methodology of a large multicentre observational
study (DESTRO).
Neurol Sci.
2004;
25
138-144
55
Spitzer R L, Kroenke K, Linzer M et al..
Health-related quality of life in primary care patients with mental disorders: results
from the PRIME-MD 1000 study.
JAMA.
1995;
274
1511-1517
56
Hays R D, Wells K B, Sherbourne C D, Rogers W, Spritzer K.
Functioning and well-being outcomes of patients with depression compared with chronic
general medical illness.
Arch Gen Psychiatry.
1995;
52
11-19
57
Wells K B, Stewart A, Hays R D et al..
The functioning and well-being of depressed patients: results from the Medical Outcomes
Study.
JAMA.
1989;
262
914-919
58
Sinyor D, Amato P, Kaloupek D G, Becker R, Goldenberg M, Coopersmith H.
Post-stroke depression: relationships to functional impairment, coping strategies
and rehabilitation outcome.
Stroke.
1986;
17
1102-1107
59
Parikh R M, Robinson R G, Lipsey J R, Starkstein S E, Fedoroff J P, Price T R.
The impact of poststroke depression on recovery in activities of daily living over
a 2-year follow-up.
Arch Neurol.
1990;
47
785-789
60
Morris P LP, Raphael B, Robinson R G.
Clinical depression is associated with impaired recovery from stroke.
Med J Aust.
1992;
157
239-242
61
Schubert D SP, Taylor C, Lee S, Mentari A, Tamaklo W.
Physical consequences of depression in the stroke patient.
Gen Hosp Psychiatry.
1992;
14
69-76
62
Ramasubbu R, Robinson R G, Flint A J, Kosier T, Price T R.
Functional impairment associated with acute poststroke depression: the Stroke Data
Bank Study.
J Neuropsychiatry Clin Neurosci.
1998;
10
26-33
63
Kauhanen M, Korpelainen J T, Hiltunen P et al..
Poststroke depression correlates with cognitive impairment and neurological deficits.
Stroke.
1999;
30
1875-1880
64
Morris P LP, Robinson R G, Andrzejewski P, Samules J, Price T R.
Association of depression with 10-year poststroke mortality.
Am J Psychiatry.
1993;
150
124-129
65
Williams L S, Ghose S, Swindle R W.
The effect of depression and other mental health diagnoses on mortality after ischemic
stroke.
Am J Psychiatry.
2004;
161
1090-1095
66
Unutzer J, Patrick D L, Simon G et al..
Depressive symptoms and the cost of health services in HMO patients aged 65 years
and older: a 4-year prospective study.
JAMA.
1997;
277
1618-1623
67
Druss B G, Rohrbaugh R M, Rosenheck R.
Depressive symptoms and health costs in older medical patients.
Am J Psychiatry.
1999;
156
477-479
68
Simon G, VonKorff M, Barlow M.
Health care costs of primary care patients with recognized depression.
Arch Gen Psychiatry.
1995;
52
850-856
69
Ghose S, Swindle R, Williams L S.
Depression and other mental health diagnoses after stroke increase inpatient and outpatient
medical utilization 3 years post-stroke.
Am J Psychiatry.
2004;
161
1090-1095
70
Carnwath T CM, Johnson D AW.
Psychiatric morbidity among spouses of patients with stroke.
BMJ.
1987;
294
409-411
71
Tompkins C A, Schulz R, Rau M T.
Post-stroke depression in primary support persons: predicting those at risk.
J Consult Clin Psychol.
1988;
56
502-508
72
Anderson C S, Linto J, Stewart-Wynne E G.
A population-based assessment of the impact and burden of caregiving for long-term
stroke survivors.
Stroke.
1995;
26
843-849
73
Dennis M, O'Rourke S, Lewis S, Sharpe M, Warlow C.
A quantitative study of the emotional outcome of people caring for stroke survivors.
Stroke.
1998;
29
1867-1872
74
Greveson G C, Gray C S, French J M, James O FW.
Long-term outcome for patients and carers following hospital admission for stroke.
Age Ageing.
1991;
20
337-344
75
Bugge C, Alexander H, Hagen S.
Stroke patients' informal caregivers: patient, caregiver, and service factors that
affect caregiver strain.
Stroke.
1999;
30
1517-1523
76
Bakas T, Austin J K, Jessup S L, Williams L S, Oberst M T.
Time and difficulty of tasks provided by family caregivers of stroke survivors.
J Neurosci Nurs.
2004;
36
95-106
77
Bakas T, Kroenke K, Plue L D, Perkins S, Williams L S.
Outcomes among family caregivers of aphasic versus non-aphasic stroke survivors.
Rehabil Nurs.
2005;
, In press
78
Carter J H, Nutt J G.
Family caregiving: a neglected and hidden part of health care delivery.
Neurology.
1998;
51
1245-1246
79
Han B, Haley W E.
Family caregiving for patients with stroke: review and analysis.
Stroke.
1999;
30
1478-1485
80
Robinson R G, Kubos K L, Starr L B, Rao K, Price T R.
Mood changes in stroke patients: importance of lesion location.
Brain.
1984;
107
81-93
81
Robinson R G, Szetela B.
Mood change following left hemispheric brain injury.
Ann Neurol.
1981;
9
447-453
82
Vataja R, Leppavuori A, Pohjasvaara T et al..
Poststroke depression and lesion location revisited.
J Neuropsychiatry Clin Neurosci.
2004;
16
156-162
83
Carson A J, MacHale S, Allen K et al..
Depression after stroke and lesion location: a systematic review.
Lancet.
2000;
356
122-126
84
Narushima K, Kosier J T, Robinson R G.
A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location
using meta-analysis.
J Neuropsychiatry Clin Neurosci.
2003;
15
422-430
85
Cassidy E, O'Connor R, O'Keane V.
Prevalence of post-stroke depression in an Irish sample and its relationship with
disability and outcome following inpatient rehabilitation.
Disabil Rehabil.
2004;
26
71-77
86
Andersen G, Vestergaard K, Ingemann-Nielsen M, Lauritzen L.
Risk factors for post-stroke depression.
Acta Psychiatr Scand.
1995;
92
193-198
87
Naess H, Nyland H I, Thomassen L, Aarseth J, Myhr K M.
Mild depression in young adults with cerebral infarction at long-term follow-up: a
population-based study.
Eur J Neurol.
2005;
12
194-198
88
Burvill P, Johnson G, Jamrozik K, Anderson C, Stewart-Wynne E.
Risk factors for post-stroke depression.
Int J Geriatr Psychiatry.
1997;
12
219-226
89
Sharpe M, Hawton K, Seagroatt V et al..
Depressive disorders in long-term survivors of stroke: associates with demographic
and social factors, functional status, and brain lesion volume.
Br J Psychiatry.
1994;
164
380-386
90
Robinson R G, Starr L B, Lipsey J R, Rao K, Price T R.
A two-year longitudinal study of post-stroke mood disorders: dynamic changes in associated
variables over the first six months of follow-up.
Stroke.
1984;
15
510-517
91 Robinson R G.
Relationship of depression to physical impairment . In: Robinson RG The Clinical Neuropsychiatry of Stroke. Cambridge, UK; Cambridge
University Press 1998: 141-149
92
Ouimet M A, Primeau F, Cole M G.
Psychosocial risk factors in poststroke depression: a systematic review.
Can J Psychiatry.
2001;
46
819-828
93
Teasdale T W, Engberg A W.
Suicide after a stroke: a population study.
J Epidemiol Community Health.
2001;
55
863-866
94
Bronnum-Hansen H, Davidsen M, Thorvaldsen P. for the Danish MONICA Study Group .
Long-term survival and causes of death after stroke.
Stroke.
2001;
32
2131-2136
95
Pohjasvaara T, Vataja R, Leppavuori A, Kaste M, Erkinjuntti T.
Suicidal ideas in stroke patients 3 and 15 months after stroke.
Cerebrovasc Dis.
2001;
12
21-26
96
Kishi Y, Robinson R G, Kosier J T.
Suicidal ideation among patients with acute life-threatening physical illness: patients
with stroke, traumatic brain injury, myocardial infarction, and spinal cord injury.
Psychosomatics.
2001;
42
382-390
97 Anderson C S, Hackett M L, House A O. Interventions for preventing depression after
stroke (Cochrane review).
In: The Cochrane Library; Issue 2 . Oxford; Update Software 2004
98 Hackett M L, Anderson C S, House A O. Interventions for treating depression after
stroke (Cochrane review).
In: The Cochrane Library; Issue 3 . Oxford; Update Software 2004
99
Lipsey J R, Robinson R G, Pearlson G D, Rao K.
Nortriptyline treatment of post-stroke depression: a double-blind study.
Lancet.
1984;
1
297-300
100
Reding M J, Orto L A, Winter S W, Fortuna I M, Di Ponte P, McDowell F H.
Antidepressant therapy after stroke: a double-blind trial.
Arch Neurol.
1986;
43
763-765
101
Ohtomo E, Hirai S, Terashi A et al..
Clinical evaluation of aniracetam on psychiatric symptoms related to cerebrovascular
disease.
J Clinical Experimental Medicine.
1991;
156
143-187
102
Andersen G, Vestergaard K, Lauritzen L.
Effective treatment of poststroke depression with the selective serotonin reuptake
inhibitor citalopram.
Stroke.
1994;
25
1099-1104
103
Robinson R G, Schultz S K, Castillo C et al..
Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery
after stroke: a placebo-controlled, double-blind study.
Am J Psychiatry.
2000;
157
351-359
104
Wiart L, Petit H, Joseph P A, Mazaux J M, Barat M.
Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.
Stroke.
2000;
31
1829-1832
105
Murray V, von Arbin M, Bartfai A et al..
Double-blind comparison of sertraline and placebo in stroke patients with minor depression
and less severe major depression.
J Clin Psychiatry.
2005;
66
708-716
106
Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebo-controlled
study with an open-label long-term follow up.
J Neurol.
2003;
250
347-351
107
Rampello L, Chiechio S, Nicoletti G et al..
Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
Psychopharmacology (Berl).
2004;
173
73-78
108
Rasmussen A, Lunde M, Poulsen D L, Sorensen K, Ovitazau S, Bech P.
A double-blind, placebo-controlled study of sertraline in the prevention of depression
in stroke patients.
Psychosomatics.
2003;
44
216-221
109
Palomaki H, Kaste M, Berg A et al..
Prevention of poststroke depression: 1 year randomized placebo controlled double blind
trial of mianserin with 6 month follow up after therapy.
J Neurol Neurosurg Psychiatry.
1999;
66
490-494
110
Niedermaier N, Bohrer E, Schulte K, Sclattmann P, Heuser I.
Prevention and treatment of poststroke depression with mirtazapine in patients with
acute stroke.
J Clin Psychiatry.
2004;
65
1619-1623
111
Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebo-controlled
study with an open-label long-term follow up.
J Neurol.
2003;
250
347-351
112
Masand P, Murray G B, Pickett P.
Psychostimulants in post-stroke depression.
J Neuropsychiatry Clin Neurosci.
1991;
3
23-27
113
Lazarus L W, Winemiller D R, Lingam V R et al..
Efficacy and side effects of methylphenidate for poststroke depression.
J Clin Psychiatry.
1992;
53
447-449
114
Shima S.
The efficacy of antidepressants in post-stroke depression.
Keio J Med.
1997;
46
25-26
115
Finklestein S P, Weintraub R J, Karmouz N, Askinazi C, Davar G, Baldessarini R J.
Antidepressant drug treatment for poststroke depression: retrospective study.
Arch Phys Med Rehabil.
1987;
68
772-776
116
Martensson B, Murray V, von Arbin M, Asberg M, Bartfai A, Malm K.
Alternative treatment of poststroke depression [letter].
Am J Psychiatry.
1997;
154
583-584
117
Lauritzen L, Bendsen B B, Vilmar T, Bendsen E B, Lunde M, Bech P.
Post-stroke depression: combined treatment with imipramine or desipramine and mianserin:
a controlled clinical study.
Psychopharmacology (Berl).
1994;
114
119-122
118
Gonzalez-Torrecillas J L, Mendlewicz J, Lobo A.
Effects of early treatment of poststroke depression on neuropsychological rehabilitation.
Int Psychogeriatr.
1995;
7
547-560
119
Spalletta G, Caltagirone C.
Sertraline treatment of post-stroke major depression: an open study in patients with
moderate to severe symptoms.
Funct Neurol.
2003;
18
227-232
120
Lincoln N B, Flannaghan T, Sutcliffe L, Rother L.
Evaluation of cognitive behavioural treatment for depression after stroke: a pilot
study.
Clin Rehabil.
1997;
11
114-122
121
Currier M B, Murray G B, Welch C C.
Electroconvulsive therapy for post-stroke depressed geriatric patients.
J Neuropsychiatry Clin Neurosci.
1992;
4
140-144
122
Boter H. HESTIA Study Group .
Multicenter randomized controlled trial of an outreach nursing support program for
recently discharged stroke patients.
Stroke.
2004;
35
2867-2872
123
Smith J, Forster A, Young J.
A randomized trial to evaluate an education programme for patients and carers after
stroke.
Clin Rehabil.
2004;
18
726-736
124
Simon G E, Ludman E J, Tutty S, Operskalski B, Von Korff M.
Telephone psychotherapy and telephone care management for primary care patients starting
antidepressant treatment: a randomized controlled trial.
JAMA.
2004;
292
935-942
125
Eriksson M, Asplund K, Glader E L et al..
Riks-Stroke Collaboration. Self-reported depression and use of antidepressants after
stroke: a national survey.
Stroke.
2004;
35
936-941
126
Jorge R E, Robinson R G, Arndt S, Starkstein S.
Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
Am J Psychiatry.
2003;
160
1823-1829
127
Narushima K, Robinson R G.
The effect of early versus late antidepressant treatment on physical impairment associated
with poststroke depression: is there a time-related therapeutic window?.
J Nerv Ment Dis.
2003;
191
645-652
128
Williams L S, Jones W J, Shen J, Robinson R L, Kroenke K.
Outcomes of newly referred neurology outpatients with depression and pain.
Neurology.
2004;
63
674-677
129
Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G.
Disease management programs for depression: a systematic review and meta-analysis
of randomized controlled trials.
Med Care.
2004;
42
1211-1221
Linda S WilliamsM.D.
Health Services Research Center (11H) Neurology
Roudebush VA Medical Center, 1481 West 10th Street
Indianapolis, IN 46202